Personalized pathology test for Cardio-vascular disease: Approximate Bayesian computation with discriminative summary statistics learning.
Personalized pathology test for Cardio-vascular disease: Approximate Bayesian computation with discriminative summary statistics learning.
复制标题
DOI:
10.1371/journal.pcbi.1009910
复制
发表时间:
2022-03
影响因子:
4.3
通讯作者:
Chopard B
中科院分区:
文献类型:
--
作者:
Dutta R;Zouaoui Boudjeltia K;Kotsalos C;Rousseau A;Ribeiro de Sousa D;Desmet JM;Van Meerhaeghe A;Mira A;Chopard B
Cardio/cerebrovascular diseases (CVD) have become one of the major health issue in our societies. But recent studies show that the present pathology tests to detect CVD are ineffectual as they do not consider different stages of platelet activation or the molecular dynamics involved in platelet interactions and are incapable to consider inter-individual variability. Here we propose a stochastic platelet deposition model and an inferential scheme to estimate the biologically meaningful model parameters using approximate Bayesian computation with a summary statistic that maximally discriminates between different types of patients. Inferred parameters from data collected on healthy volunteers and different patient types help us to identify specific biological parameters and hence biological reasoning behind the dysfunction for each type of patients. This work opens up an unprecedented opportunity of personalized pathology test for CVD detection and medical treatment. Cardiovascular accidents often result from blood deficiencies, such as platelets dysfunction. Current diagnosis techniques to detect such dysfunctions are not sufficiently accurate and unable to determine which platelet properties are affected. We develop a novel approach to describe in-vitro platelets deposition patterns in terms of clinically meaningful patient specific bio-physical quantities that allow for personalized clinical diagnostics. This approach combines mathematical modeling, statistical inference techniques, machine learning and high performance computation to estimate the values of these clinically relevant platelet properties. We demonstrate our approach on three classes of donors, healthy volunteers, patients subject to dialysis and patients with chronic obstructive pulmonary disease. We claim that our approach opens a paradigm shift for the treatment and diagnosis of cardiovascular diseases, leading to personalized medicine.
登录
查看更多内容
影响因子:
6.5
作者:
Lintusaari J;Gutmann MU;Dutta R;Kaski S;Corander J
通讯作者:
Corander J
影响因子:
5.6
作者:
Koltai K;Kesmarky G;Feher G;Tibold A;Toth K
通讯作者:
Toth K
影响因子:
120.7
作者:
Breet, Nicoline J.;van Werkum, Jochem W.;ten Berg, Jurrien M.
通讯作者:
ten Berg, Jurrien M.
DOI:
10.1111/j.2517-6161.1995.tb02031.x
发表时间:
1995-01-01
影响因子:
5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者:
HOCHBERG, Y
影响因子:
3.4
作者:
Bian X;Kim C;Karniadakis GE
通讯作者:
Karniadakis GE